OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Angelika Wagner, Birgit Weinberger
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Susanne H. Hodgson, Kushal Mansatta, Garry Mallett, et al.
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 2, pp. e26-e35
Open Access | Times Cited: 640

COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 355

Immunology of Aging: the Birth of Inflammaging
Tamàs Fülöp, Anis Larbi, Graham Pawelec, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 64, Iss. 2, pp. 109-122
Open Access | Times Cited: 263

The Complex Role of Regulatory T Cells in Immunity and Aging
Lourdes Rocamora‐Reverte, Franz Leonard Melzer, Reinhard Würzner, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 171

Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Branca Pereira, Xiao‐Ning Xu, Arne N. Akbar
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 138

What can we expect from first-generation COVID-19 vaccines?
Malik Peiris, GM Leung
The Lancet (2020) Vol. 396, Iss. 10261, pp. 1467-1469
Open Access | Times Cited: 103

Immunosenescence is both functional/adaptive and dysfunctional/maladaptive
Tamàs Fülöp, Anis Larbi, K. Hirokawa, et al.
Seminars in Immunopathology (2020) Vol. 42, Iss. 5, pp. 521-536
Open Access | Times Cited: 88

“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 73

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47

Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Tamàs Fülöp, Anis Larbi, Graham Pawelec, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 607-607
Open Access | Times Cited: 40

Adjuvants for COVID-19 Vaccines
Javier Castrodeza, Iván Sanz-Muñoz, José María Eirós Bouza
Vaccines (2023) Vol. 11, Iss. 5, pp. 902-902
Open Access | Times Cited: 31

The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein
Victoria A. Jenkins, Bernard Hoet, Hubertus Hochrein, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 382-382
Open Access | Times Cited: 19

Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge model
Stephanie Ascough, Pete Dayananda, Mohini Kalyan, et al.
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 6, pp. e405-e416
Open Access | Times Cited: 28

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
Eustache Paramithiotis, Scott Sugden, Eszter Papp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Precision Vaccine Adjuvants for Older Adults: A Scoping Review
Etsuro Nanishi, Asimenia Angelidou, Chloe Rotman, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_1, pp. S72-S80
Open Access | Times Cited: 24

Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review
Christelle Elias, Marta C. Nunes, Mitra Saadatian‐Elahi
Current Opinion in Infectious Diseases (2024)
Open Access | Times Cited: 6

Targeting immunosenescence for improved tumor immunotherapy
Zaoqu Liu, Lulu Zuo, Zhaokai Zhou, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 5

Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects
Anna Sandionigi, Alessandra De Giani, Francesco Tursi, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 21

Revolutionizing and identifying novel drug targets in Citrobacter koseri via subtractive proteomics and development of a multi-epitope vaccine using reverse vaccinology and immuno-informatics
Israr Fatima, Fahad M. Alshabrmi, Tariq Aziz, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access | Times Cited: 4

COVID-19 Vaccines in Older Adults
Chih‐Kuang Liang, Wei‐Ju Lee, Li‐Ning Peng, et al.
Clinics in Geriatric Medicine (2022) Vol. 38, Iss. 3, pp. 605-620
Open Access | Times Cited: 18

Anti-Inflammatory Effects of Nutritionally Relevant Concentrations of Oleuropein and Hydroxytyrosol on Peripheral Blood Mononuclear Cells: An Age-Related Analysis
Fanny Pojero, Francesco Gervasi, S. Fiore, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11029-11029
Open Access | Times Cited: 10

Aging and the challenges of vaccination
Ava Ghezel, Masoud Keikha, Chista Sarira Arfaee
Vacunas (2025)
Closed Access

Page 1 - Next Page

Scroll to top